Quantcast
Last updated on April 17, 2014 at 12:39 EDT

Latest epigenomics Stories

2013-09-25 08:29:33

G3's Cardiovascular Disease Biomarker and Drug Target Discovery Study (the "GLOBAL" Study) is the Single Largest Prospective Pan-Omic Study to Employ Whole Genome Sequencing RICHMOND, Va., and SAN DIEGO, Sept. 25, 2013 /PRNewswire/ -- Global Genomics Group (G3) and Illumina, Inc. (NASDAQ: ILMN) today announced that they have entered into a partnership to investigate novel biomarkers and biological pathways involved in the development and diagnosis of cardiovascular diseases. Under...

2013-09-11 23:02:59

Insightful research study “Epigenetics Technology Market (Epigenomics, DNA Methylation, Histone Modifications, RNA Interference, Cancer Therapeutics, Personalized Medicine) (2012 - 2017)” worked out by MarketsandMarkets (M&M) has been recently published by Market Publishers Ltd. According to the report, the global epigenetics market witnessed a CAGR of 25% during 2008-2012. London, UK (PRWEB) September 11, 2013 The global epigenetics market has witnessed sustainable growth...

2013-07-23 13:31:35

New technique can rapidly turn genes on and off, helping scientists better understand their function. Although human cells have an estimated 20,000 genes, only a fraction of those are turned on at any given time, depending on the cell’s needs — which can change by the minute or hour. To find out what those genes are doing, researchers need tools that can manipulate their status on similarly short timescales. That is now possible, thanks to a new...

2013-06-26 08:30:19

ALBANY, New York, June 26, 2013 /PRNewswire/ -- According to a new market report published by Transparency Market Research (http://www.transparencymarketresearch.com) "Epigenetics Drugs and Diagnostic Technologies Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," the global epigenetic drugs and diagnostic technologies market was valued at USD 1.6 billion in 2011 and is estimated to reach a market worth USD 5.7 billion in 2018 at a CAGR...

2013-06-18 13:14:30

Methylation refers to a chemical modification of DNA and this modification can occur in millions of positions in the DNA sequence. Until now, scientists believed that this epigenetic phenomenon actively reduced the expression of certain genes. Today, a team of researchers from the University of Geneva (UNIGE), Switzerland, led by Emmanouil Dermitzakis, Louis-Jeantet Professor at the Faculty of Medicine, reveals that this is not always the case and that DNA methylation may play both a passive...

2013-06-13 23:27:32

RiboMed Biotechnologies, Inc. (http://www.ribomed.com), a company that develops epigenetic-based tests that provide improved cancer diagnosis and allow drug therapy to be personalized for the benefit of cancer patients, today announced that it has partnered with researchers at the Austrian Institute of Technology (AIT, Vienna) to commercialize their clinically validated lung cancer DNA methylation biomarkers. Lung cancer is the number-one cause of cancer deaths in both men and women in the...

2013-06-10 12:27:51

A study led by St. Jude Children's Research Hospital shows epigenetic changes that turn genes on and off are as unique as alterations in DNA and may be as important in causing the most common childhood cancer MEMPHIS, Tenn., June 10, 2013 /PRNewswire-USNewswire/ -- Changes in an epigenetic mechanism that turns expression of genes on and off may be as important as genetic alterations in causing pediatric acute lymphoblastic leukemia (ALL), according to a study led by scientists...

2013-06-07 00:20:36

Featured Research to Describe First Demonstration of De Novo Assembly of the Human Genome Using Irys System SAN DIEGO and PARIS, June 7, 2013 /PRNewswire/ -- BioNano Genomics announced today the availability in the European Union of the Irys(TM) System for genome mapping. In conjunction with the European Human Genetics Conference 2013 being held in Paris from June 8 to 11, BioNano and collaborator Pui-Yan Kwok, M.D., Ph.D., Henry Bachrach Distinguished Professor at the University of...

2013-03-07 15:20:25

Salk epigenetic findings may aid in crop production Scientists at the Salk Institute for Biological Studies have identified patterns of epigenomic diversity that not only allow plants to adapt to various environments, but could also benefit crop production and the study of human diseases. Published March 6 in Nature, the findings show that in addition to genetic diversity found in plants throughout the world, their epigenomic makeup is as varied as the environments in which they are...

2013-01-21 23:04:11

Currently North America dominates with 40% of market share, followed by Europe with 36% (PRWEB) January 21, 2013 The report “Epigenetics Technology Market (Epigenomics, DNA Methylation, Histone Modifications, RNA interference, Cancer Therapeutics, Personalized Medicine) (2012 - 2017)” analyses the global epigenetics market by region, applications and epigenetic mechanisms with five year revenue forecasts. It also identifies the factors driving and restraining the global...